3',3'-cyclic GMP-AMP (cGAMP) is the third cyclic dinucleotide (CDN) to be discovered in bacteria. No activators of cGAMP signaling have yet been identified, and the signaling pathways for cGAMP have appeared narrowly distributed based upon the characterized synthases, DncV and Hypr GGDEFs. Here we report that the ubiquitous second messenger cyclic AMP (cAMP) is an activator of the Hypr GGDEF enzyme GacB from Myxococcus xanthus. Furthermore, we show that GacB is inhibited directly by cyclic di-GMP, which provides evidence for crossregulation between different CDN pathways. Finally, we reveal that the HD-GYP enzyme PmxA is a cGAMP-specific phosphodiesterase (GAP) that promotes resistance to osmotic stress in M.
including the environmental species Geobacter sulfurreducens, predatory species Bdellovibrio bacteriovorus (now within the class Oligoflexia), and social species Myxococcus xanthus. GACs are structurally related to the GGDEF family of diguanylate cyclases (DGCs), which are classically associated with cyclic di-GMP signaling, but instead have 'Hypr' GGDEF domains harboring specific variations in the active site that favor cGAMP production (9) . We recently demonstrated that the Hypr GGDEF GSU1658 (GsGacA) from Geobacter sulfurreducens regulates cGAMP but not cyclic di-GMP levels in vivo, resulting in a specific phenotype distinct from the biofilm-associated phenotype for the DGC EsnD (7) .
While our focus to date has been on understanding the basis for cGAMP production by GACs with Hypr GGDEF domains (7, 9) , the regulation of GAC activity is relatively unexplored ( Fig. 1 ). Specifically, it was not known how the conserved inhibitory site (I-site) often found in GGDEF domains acts to regulate Hypr GGDEF enzymes. Also, no activator of bacterial cGAMP signaling has yet been identified. GsGacA and its homologs in other bacteria contain receiver (Rec) domains, but the partner histidine kinases and their signal inputs have not been identified.
Based on structural and in vitro evidence, V. cholerae DncV is proposed to be inhibited by folates (10) , but this effect has not been tested in vivo. In any case, DncV does not appear to require activation by an exogenous factor.
To elucidate these missing parts of the Hypr-cGAMP signaling pathway and to broaden its scope to other bacteria, we have analyzed the system in the social bacterium Myxococcus xanthus. M. xanthus contains two GACs, MXAN_4463 (MxGacA) and MXAN_2643 (MxGacB), with Rec-GGDEF and GAF-GGDEF domain architectures, respectively ( Fig. 2A) . MxGacA is homologous to GsGacA and has an orphan receiver domain that lacks an associated histidine kinase. Aravind and colleagues first identified the GAF domain by bioinformatics and coined the name for its presence in cGMP-specific phosphodiesterases, Anabaena adenylate cyclases, and Escherichia coli FhlA (11) . Since then, GAF domains have been shown to respond to a diverse set of small molecule signals, including cyclic nucleotides, amino acids, and metabolites, as well as redox and light (12) (13) (14) (15) (16) (17) . Our initial in vitro experiments with MxGacB included measuring enzyme activity in the presence of ATP, GTP, and related analogs. Serendipitously, high activity was observed in the presence of millimolar levels of ATP, which had not been observed with
GsGacA, a Rec-GGDEF. This led to the hypothesis that an adenine-containing compound may be a physiological activator of MxGacB (herein referred to as GacB).
To identify the activator of GacB, an in vitro screen was conducted by incubating GacB with equimolar amounts of ATP and GTP substrates, with or without addition of candidate activators. A sum of all cyclic dinucleotide products was measured due to the promiscuous nature of GACs in vitro, an activity also seen with GsGacA under these conditions (9) . Only cAMP increased GacB activity (~2.7x) when added at a 10 µM concentration (Fig. 2B ). Using a radiolabeled thin-layer chromatography (TLC) assay with GTP as the substrate to simplify product analysis, the effective concentration for GacB activation by cAMP (EC 50 ) was found to be ~79 nM (Fig. 2C) . A thermal shift assay conducted with the GAF domain of GacB (GacB shows that cAMP gives the greatest stabilization effect relative to other nucleotide ligands ( Fig.   2D ), supporting that the cyclic nucleotide binds in this domain. Taken together, these results demonstrate that cAMP is a selective activator that enhances GacB activity upon binding to the GAF domain.
GAF domains from bacteria and eukaryotes that bind cAMP or cGMP have been previously identified and structurally analyzed (12) , including a recent structure of a cAMPbinding DGC enzyme, Lcd1 from Leptospira interrogans (18) . However, to our knowledge, this is the first evidence linking cAMP signaling to cGAMP signaling, which expands the type of cAMP effectors in bacteria to include GAC enzymes. In addition, cAMP is the first identified small molecule activator of cGAMP synthesis, which provides insight into the physiological role of this signaling pathway in Myxobacteria, as GacB is conserved within the genus and in the related fruiting Myxobacteria Corallococcus coralloides and Stigmatella aurantiaca (19) Besides regulation by sensory domains like the GAF domain, canonical GGDEF domaincontaining DGCs also contain an allosteric inhibitory site (I-site) that binds cyclic di-GMP and leads to allosteric feedback inhibition of DGC activity (20) . However, since GacB is a GMP-AMP cyclase with a divergent Hypr GGDEF domain, we had to consider whether it was selectively regulated by a given cyclic dinucleotide. GacB could be subject to product autoinhibition by cGAMP, or it could be cross-regulated by cyclic di-GMP or cyclic di-AMP. Recent studies of GsGacA yielded phenotypic and transcriptomic evidence consistent with crossinhibition by cyclic di-GMP, but did not show a direct mechanism (7) .
In our initial inhibition assays, both ATP and GTP were used as substrates, which complicated the analysis as GacB produced all three bacterial cyclic dinucleotides in situ ( Fig.   S1 ). We predicted that cyclic di-AMP was least likely to interact with GacB due to its structural dissimilarity to cyclic di-GMP, the canonical inhibitor of GGDEF enzymes. Therefore, the assays were repeated using ATP as the sole substrate, taking advantage of the in vitro promiscuity of GacB so that only cyclic di-AMP was produced in situ. Clear inhibition of enzyme activity was observed with 10 µM of cyclic di-GMP but with none of the other cyclic dinucleotides (Fig. 3A ). We tested two potential mutants to knock out the I-site, GacB R286A and R292 (data not shown), and found that both had lower activity relative to WT, but R286A was not inhibited by cyclic dinucleotides. The IC 50 value was determined to be 17.80 +/-1.06 µM for WT GacB inhibition by cyclic di-GMP ( Fig. 3B ), which is similar to the published IC 50 value (5.1 +/-1.4 µM) for the DGC PleD by cyclic di-GMP (21) .
We also conducted a thermal shift assay of full length GacB WT and R286A with various amounts of each CDN. Significant stabilization of GacB WT was only observed with 10 µM of cyclic di-GMP, which is consistent with the activity assays and measured IC 50 value ( Fig. 3C ).
GacB R286A was not stabilized by cyclic dinucleotides. Thus, cyclic di-GMP binds and inhibits both Hypr and canonical GGDEF enzymes via the conserved I-site. However, whereas I-site regulation leads to auto-inhibition for DGCs, our data strongly support that inhibition of GacB by cyclic di-GMP instead is a mechanism for cross-regulation of cGAMP signaling by cyclic di-
GMP.
Signal output can be decreased by inhibition of cGAMP synthesis or by degradation of cGAMP. So far, no cGAMP-specific PDE has been identified in bacteria. Three PDEs harboring HD-GYP domains from V. cholerae, including VC0681, were shown to degrade 3',3'-cGAMP in preference to the mammalian mixed-linkage 2',3'-cGAMP. When 3',3'-linkage cyclic dinucleotides are compared, however, VC0681 clearly favors degradation of cyclic di-GMP over 3',3'-cGAMP (22) . VC0681 previously was shown to control cyclic di-GMP levels in V. cholerae (23), so does not appear to act as a cGAMP-specific PDE in cells.
We had hypothesized that the 'erasers' involved in cGAMP signaling would be specific, but still may have evolved from components of cyclic di-GMP signaling, in line with how we discovered GACs and cGAMP-specific riboswitches as sub-classes of GGDEF enzymes and GEMM-I riboswitches, respectively (9, 24, 25) . In both cases, it was possible to identify specific residues in the active site or ligand binding pocket that rationally reprogrammed the synthase or riboswitch to gain new specificities. The M. xanthus genome contains six HD-GYP and two EAL domain containing genes that are candidate phosphodiesterases. Based on structure-guided sequence analysis, both M. xanthus EAL proteins contain conserved residues that enforce selectivity for cyclic di-GMP (26) . However, when we compared to the HD-GYP domain from PmGH, a cyclic di-GMP PDE, we found that one M. xanthus HD-GYP protein does not harbor the two basic residues, R314 and K317, of the conserved Rxx(K/R) motif that recognizes a guanine nucleobase of cyclic di-GMP (27) . This exception was MXAN_2061, also called PmxA, which contains an R515 and Q518 pair instead. In vitro studies identified PmxA as a cyclic di-GMP PDE, but deletion of this gene did not show significant changes in cyclic di-GMP levels in vivo (28) . The switch from a hydrogen-bond donor (K/R) to a potential hydrogen-bond acceptor (Q) was promising for altering specificity toward cGAMP ( Fig. 4 ).
PmxA is a multi-domain protein, composed of two transmembrane regions, a coiledcoiled HAMP domain, and the catalytic C-terminal HD-GYP domain (Fig. 4A ). The Søgaard-Andersen group previously identified a truncated PmxA construct that contains the HD-GYP domain that was soluble and active, as well as developed buffer conditions to assay its PDE activity (28) , which were critical advances for in vitro studies ( Fig. 5A ). Using an MBP-tagged version of this construct, we detected robust degradation of cGAMP after 4 h, whereas little to no degradation was observed for cyclic di-GMP and cyclic di-AMP under the same conditions (Fig.   5B ). The AA-GYP double mutant rendered the PDE inactive toward cGAMP, confirming that the HD-GYP domain was necessary for this activity (Fig. S2 ).
To test whether the Q518 residue was responsible for the unique substrate selectivity of PmxA, the activity of the Q518R mutant PmxA was analyzed. This mutant exhibited little to no degradation of cGAMP after 4 h, and instead gained activity against cyclic di-GMP ( Fig. 5B ).
The substrate selectivity of this point mutant is comparable to the published activity of v-cGAP1 (VC0681), which harbors an R residue at this position (22) . To our knowledge, PmxA is the first bacterial PDE shown to preferentially degrade 3',3'-cGAMP over cyclic di-GMP. Moreover, our data reveal that Q518 may serve as a signature residue for the sub-class of HD-GYP domains that act specifically as cyclic GMP-AMP phosphodiesterases (GAPs).
To investigate the regulatory function of cGAMP signaling in M. xanthus, the phenotype of a wild type strain (DZ2) was compared to the corresponding ΔgacB and ΔpmxA mutants. In a different strain, M. xanthus DK1622, the ΔpmxA mutant did not show a motility phenotype (19) .
Type IV pilus (T4P)-dependent motility, a.k.a. twitching or social motility, was assayed on CYE plates that contained 0.5% agar. ΔgacB slightly increased colony expansion (+22%) relative to WT, whereas ΔpmxA had the opposite effect (-24%) ( Fig. 6A ). These data indicate that cGAMP mildly inhibits T4P-dependent motility under these conditions. Earlier studies reported that osmotic stress increases the concentration of cAMP in M.
xanthus (29, 30) . Since cAMP activates the synthase activity of GacB (Fig. 2B ), we hypothesized that cGAMP may have a role during osmotic stress. Osmotic stress was induced by addition of high salt (0.15 M NaCl) to the growth medium. Under osmotic stress, we expected that cAMP stimulation of GacB activity should lead to higher cellular cGAMP concentrations that further inhibit T4P-dependent motility, whereas PmxA activity should have the opposite effect.
However, we found that osmotic stress overall inhibits T4P-dependent motility in the wild type, ΔgacB, and ΔpmxA mutants ( Fig. 6A ). Consistent with the mild inhibitory phenotype observed for cGAMP, the ΔgacB strain that should produce less cGAMP than WT has slightly increased colony expansion (+14%) relative to WT, but the ΔpmxA mutant retained similar colony expansion compared to the wild type under high osmotic stress, even though it is predicted to have higher cGAMP levels. Taken together, our data suggest that cGAMP is not a major regulator of T4P-dependent motility in M. xanthus. These results contrast with cyclic di-GMP signaling in M. xanthus, which has been shown to strongly inhibit T4P-dependent motility (19) , thus underscoring that cGAMP signaling is a distinct pathway from cyclic di-GMP in this organism.
Instead, we observe a developmental phenotype for cGAMP signaling that is apparent upon osmotic stress. M. xanthus form fruiting bodies to resist harsh environmental stresses and are induced, for example, under starvation conditions. When starved on CF agar in the absence of osmotic stress, all three tested strains (WT, ΔpmxA, and ΔgacB) formed fruiting bodies, albeit the fruiting bodies formed by the ΔpmxA strain are more peripheral. In contrast, in the presence of osmotic stress, only ΔpmxA is capable of forming fruiting bodies ( Fig. 6B ). This striking result indicates that high cGAMP levels provide resistance against osmotic stress during M. xanthus fruiting body formation. In a different strain, M. xanthus DK1622, the ΔpmxA mutant was shown to exhibit developmental defects, including irregular, translucent fruiting body formation and sporulation at 15% of WT levels without osmotic stress (28) .
To further explore the function of PmxA and its homologs in cells, we developed a fluorescent biosensor assay for PDE activity based on RNA-based fluorescent (RBF) biosensors.
RBF biosensors specific for each of the bacterial cyclic dinucleotides have been used previously to analyze synthase activities (31) . This assay was adapted to screen PDE activities by encoding a candidate PDE in one plasmid and a matched pair of biosensor and synthase on a second plasmid ( Fig. 7A ). For example, the DGC WspR was co-expressed with the Dp biosensor, which responds to cyclic di-GMP (32) , and the well-characterized GAC GsGacA was co-expressed with the Gm biosensor, which responds to cGAMP (24) . These two matched synthase-sensor pairs result in highly fluorescent (bright) cell populations as measured by flow cytometry. Coexpression of an active PDE then should cause the bright cell population to decrease, due to degradation of the cyclic dinucleotide sensed by the RBF biosensor. Thus, PDE selectivity can be preliminarily assessed by screening against the two synthase-sensor pairs.
Since this assay requires balanced co-expression of three components (synthase, biosensor, and PDE), growth and induction conditions had to be optimized, especially for a highthroughput, 96-well format. Two factors that significantly improved assay results were the culture volume per well and % lactose in the autoinduction media. We also found that the addition of a third component, even an inactive protein (PmxA mut, Fig. S2 ), leads to a mixed population of bright and dark cells rather than a single bright population as seen in prior studies co-expressing just synthase and biosensor ( Fig. 7B, C ). Most likely, this effect is due to stochastically reduced synthase activity from non-uniform expression levels. The synthases are particularly sensitive to this, because as GGDEF enzymes they are active only as dimers or higher order oligomers.
To assess PDE activity in the context of these bifurcated cell populations, we decided to analyze the percentage of the bright cells in the sample. Using this approach, it was verified that wild-type PmxA decreases the population of cGAMP-bright cells relative to the inactive PmxA mutant, but it has no effect on the population of cyclic di-GMP-bright cells (Fig. 7B, C) . This result shows that PmxA is a cGAMP-specific PDE in the live cell context and corroborates our biochemical data.
We had expected the opposite trend upon addition of PdeH, which is a well-studied cyclic di-GMP-specific PDE from E. coli previously called YhjH (33, 34) . While PdeH did decrease the population of cyclic di-GMP-bright cells (Fig. 7C) , it counterintuitively increased the population of cGAMP-bright cells. One reasonable explanation for this effect is that PdeH de-represses the GsGacA synthase by lowering global cyclic di-GMP levels in E. coli. This result is in line with our demonstration that GAC activity is inhibited by cyclic di-GMP in vitro ( Fig.  3 ), is consistent with reporter assay results in G. sulfurreducens (9) , and further supports that this cross-regulation occurs in cells.
With this assay and analysis method validated using PmxA and PdeH, it was applied to screen HD-GYP domains from other bacteria for cGAMP-specific PDE (GAP) activity. We first performed a bioinformatic search outside the Myxococcus genus for HD-GYP domains homologous to PmxA that harbor the RxxQ motif, which was shown to be important for cGAMP specificity. HD-GYP domains with the RxxN motif were added to this search, as N contains an amide functional group similar to Q. The majority of homologs (87.97%) harbored the canonical Rxx(K/R) motif, but 539 sequences (4.69%) contained an Rxx(Q/N) sequence (Fig. 8A) .
Excitingly, while some candidates are from bacterial species previously predicted to have cGAMP signaling due to the presence of the synthase (9), the majority are from bacterial species not previously associated with cGAMP signaling (Fig. 8B ). Candidate GAPs appear well which included 10 mM Mg 2+ as the added divalent metal (Fig. 9A, B ). However, different divalent metals and pH have been shown to enhance HD-GYP activity (22, 35) , as HD-GYP active sites are known to contain redox-sensitive bi-and tri-nuclear cores with variable metal selectivity (36) (37) (38) . We screened Bd2325 with different metals (Mg 2+ , Mn 2+ , Ca 2+ , Fe 2+ , and Ni 2+ , Fig. S3 ) and pH ranges (data not shown), and indeed found that two types of divalent metals activate the enzyme in vitro.
Bd2325 is most active in the presence of Mn 2+ , as it degraded both cGAMP and cyclic di-GMP to their respective linear dinucleotides within 4 h (Fig. 9A, B) . In fact, under these conditions, this enzyme degraded a measurable amount of cGAMP within the ~30 seconds required to prepare the '0' minute time point of a time course, but was less active against cyclic di-GMP (Fig. S4) . Observation of the linear dinucleotide product contrasts with the mononucleotides AMP and GMP detected with PmxA. HD-GYP protein TM0186 from Thermotoga maritima shifts from production of linear to mononucleotide product depending on active site metal occupancy, which may also be true for other HD-GYP PDEs (38) . The preference for cGAMP was even clearer in the presence of Ni 2+ . After 4 h, cGAMP was fully degraded, but the majority of the cyclic di-GMP sample remained. Thus, these in vitro experiments confirm that variant HD-GYP domains harboring either the RxxQ or RxxN motifs are selective for cGAMP over cyclic di-GMP.
According to our bioinformatics analysis, the newfound GAP enzymes are more widespread in bacteria than the known set of Hypr GGDEF synthases and cGAMP riboswitches that have defined the Hypr-cGAMP signaling pathway to date. Thus, it is plausible that they also play a role in the DncV-cGAMP signaling pathway, although the previously described v-cGAPs in V. cholerae do not harbor the active site variations that give rise to cGAMP specificity. Going forward, it will be interesting to determine whether these two cGAMP signaling pathways have points of convergence, like utilizing the same PDE class, or will remain completely distinct from one another in terms of signaling components. A further intriguing possibility we want to pursue is that some HD-GYP variants may have activity against newly discovered cyclic dinucleotide signals (39) . There is still high potential for novel enzyme classes associated with cyclic dinucleotide signaling, as well as novel effectors that bind cyclic dinucleotides.
When cellular signaling pathways are highly integrated, phenotype-based studies may become challenging to interpret or use for deconvoluting pathways and discovering novel components. To address this issue, we have worked on developing high-throughput fluorescence assays that read out specific cyclic dinucleotide levels in vivo (31) . We recently showed that RBF biosensors can be applied to detect modulation of endogenous cyclic di-GMP signaling (40, 41 ). Here we show for the first time that RBF biosensors can be used to discover and evaluate specific PDE activity.
Taken together, this study expands our knowledge of how cGAMP signaling is regulated, by identifying the first activator molecule, cAMP, and the founding members of a class of cGAMP specific phosphodiesterases (GAPs). In addition, we show that cGAMP signaling is integrated with other nucleotide signaling pathways via allosteric regulation of the synthase, GacB, by cAMP and cyclic di-GMP. This result reinforces the growing appreciation that nucleotide signaling pathways form an integrated, multi-layered network, allowing bacterial cells to respond in a coordinated, sophisticated manner to complex feedback from their environment and metabolic status.
MATERIALS AND METHODS

In Vitro Activity Assay for GacB
For activation assays, 6xHis-MBP GacB WT (0.5 µM) was incubated in a 50 µL solution of 50 mM Tris-HCl pH 7.5, 10 mM MgCl 2 , 100 mM NaCl, and 5 mM dithiothreitol, with both substrates (ATP and GTP) at 1 mM each and 1 µM of candidate activators (cAMP, cGMP, adenosine, AMP, ADP, or none). Reaction mixtures were incubated at 37 °C for 6 h, heated to 95 °C for 30 s to denature the protein, then centrifuged for 3 min at 13,000 rpm to remove precipitate. For LC-MS analysis, 20 µL of the sample was injected, and starting materials and products were confirmed by mass and quantified by peak area at 254 nm absorbance.
Inhibition assays were performed following the same protocol as above, with the following changes. 6xHis-MBP GacB WT (0.5 µM) was first incubated in reaction buffer with 10 µM of candidate inhibitors (cGAMP, cdiG, cdiA, or none) for 10 min at room temperature.
Then substrate (1 mM ATP) was added to start the reaction. Signal was measured by ion extraction of respective CDN m/z values: 659 m/z cdiA, 675 m/z cGAMP, 691 m/z cdiG. The IC 50 value for GacB was obtained using this protocol, but with varied amounts of cdiG between 0-100 µM.
Activity Assay for Phosphodiesterases using LC-MS
The protocol was adapted from previously published methods for PmxA developed by Skotnicka 
Myxococcus xanthus Phenotypic Assays
To construct the in-frame deletion strains, in-frame deletion mutation cassettes were amplified with polymerase chain reaction (PCR) using chromosomal DNA as template, digested and inserted into plasmid pBJ113. All constructs were confirmed by DNA sequencing. To generate mutant strains, transformants were obtained by homologous recombination as previously 
